Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea · Delayed Price · Currency is KRW 4,875.00
+375.00 (8.33%)
At close: Jan 23, 2026
Genesystem Market Cap
Genesystem has a market cap or net worth of 33.25 billion as of January 23, 2026. Its market cap has decreased by -43.58% in one year.
Market Cap
33.25B
Enterprise Value
35.96B
Revenue
345.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
4,875.00
Market Cap Chart
Since May 26, 2021, Genesystem's market cap has decreased from 118.51B to 33.25B, a decrease of -71.94%. That is a compound annual growth rate of -23.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 33.25B | 18.90% |
| Dec 30, 2025 | 27.96B | -52.89% |
| Dec 30, 2024 | 59.36B | -8.92% |
| Dec 28, 2023 | 65.17B | 12.35% |
| Dec 29, 2022 | 58.00B | -26.36% |
| Dec 30, 2021 | 78.77B | -33.54% |
| May 26, 2021 | 118.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Remed | 86.39B |
| Hironic | 74.74B |
| JPI Healthcare | 73.01B |
| DRGEM | 59.38B |
| Neofect | 52.19B |
| Genoray | 51.20B |
| UXN Co., Ltd. | 40.50B |
| CU Medical Systems | 35.53B |